Randomized Trialmoderate evidence
Effect of transdermal testosterone on postmenopausal sexual desire: placebo-controlled randomized clinical trial.
European journal of obstetrics, gynecology, and reproductive biology·August 1, 2026·PMID 42302467
Why it mattersTransdermal testosterone is used off-label for hypoactive sexual desire in postmenopausal women, but evidence on compounded formulations is limited. This study provides efficacy and safety signals relevant to clinicians managing sexual health in menopause.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled